Aesthetic device company Alma invited clinic owners to its Alma Academy at Kings Place, London, on June 8. The morning featured talks from aesthetic practitioners Dr Hen Ifrach, Dr Munir
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the first glucagon-like peptide-1 (GLP-1) receptor agonist weight-loss tablet for use in the UK. The once-daily semaglutide tablet, marketed by
A new investigational drug called apitegromab is being explored to preserve muscle mass in adults receiving glucagon-like peptide‑1 (GLP‑1) receptor agonists for obesity. The BBC has reported on a Nature Medicine study
Aesthetic distributor DermaFocus has announced its first online training programme for medical professionals. The live course, delivered via the company’s educational platform RISE, offers an introduction to exosome science and
UK-based charitable organisation Mast Cell Action is partnering with compounding pharmacy Roseway Labs in recognition of Mast Cell Activation Syndrome (MCAS) Awareness Month. The formal partnership follows a year of
Skincare company Skin Diligent has unveiled its new Vitamin C Serum-in-Oil. According to the company, the formulation features Ascorbyl Tetraisopalmitate, a lipid-soluble derivative of vitamin C selected for its stability
Four practitioners consider the evolving role of skin boosters in skin health optimisation Skin boosters are injectable formulations, most commonly based on non or lightly cross-linked hyaluronic acid (HA), designed to improve skin quality rather than alter facial contours. Unlike …
The Joint Council for Cosmetic Practitioners (JCCP) has issued a clarification on the role of dental professionals in non-dental cosmetic procedures, following concern over recent changes to the General Dental
The US Food and Drug Administration (FDA) has announced it will re-evaluate the regulatory status of several widely discussed therapeutic peptides, including BPC-157, KPV and Semax. Under current US compounding
Pharmaceutical company Galderma has been announced as Headline Sponsor for the Clinical Cosmetic Regenerative Congress (CCR) 2026. Galderma will have a presence across the scientific programme and exhibition floor, providing
